Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache

Código QR

Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache

Stefan EversDepartment of Neurology, University of M&uuml;nster, M&uuml;nster, GermanyAbstract: Botulinum toxin A is increasingly used in the treatment of idiopathic and symptomatic headache disorders. However, only few controlled trials are available and many trials can hardly be co...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Stefan Evers
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2007
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6cdba5a938434a199a8041bd15a8efbf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
por: Robertson CE, et al.
Publicado: (2012)

The classification of chronic daily headache in French children and adolescents: A comparison between the second edition of the International Classification of Headache Disorders and Silberstein-Lipton criteria
por: Jean-Christophe Cuvellier, et al.
Publicado: (2008)

Neurologic uses of botulinum neurotoxin type A
por: John P Ney, et al.
Publicado: (2007)

Forehead carbuncle with intractable headache
por: Chou PY, et al.
Publicado: (2015)

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin&reg;), a botulinum neurotoxin type A free from complexing proteins
por: Jimenez-Shahed J
Publicado: (2011)

Can headache impair intellectual abilities in children? An observational study
por: Esposito M, et al.
Publicado: (2012)

What is the impact of physician communication and patient understanding in the management of headache?
por: Meenal Patwardhan, et al.
Publicado: (2007)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Brandon C Strange
Publicado: (2008)

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong H, et al.
Publicado: (2018)

Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy
por: Guidotti M, et al.
Publicado: (2013)

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao S, et al.
Publicado: (2017)

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review
por: Mijajlović MD, et al.
Publicado: (2014)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
por: Antonini A, et al.
Publicado: (2011)

Hearing voices: does it give your patient a headache? A case of auditory hallucinations as acoustic aura in migraine
por: Van der Feltz-Cornelis CM, et al.
Publicado: (2012)

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
por: Yu RL, et al.
Publicado: (2015)

Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children
por: Evatt ML
Publicado: (2011)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott J, et al.
Publicado: (2012)

Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
por: Zhu W, et al.
Publicado: (2014)

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin B, et al.
Publicado: (2021)

Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer&rsquo;s disease: A case report study
por: St&eacute;phanie Thivierge, et al.
Publicado: (2008)

Frequency of anemia in chronic psychiatry patients
por: Korkmaz S, et al.
Publicado: (2015)

Psychiatric comorbidity and suicide risk in patients with chronic migraine
por: Maurizio Pompili, et al.
Publicado: (2010)

Changes in proinflammatory cytokines and white matter in chronically stressed rats
por: Yang P, et al.
Publicado: (2015)

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus
por: Gül Aİ, et al.
Publicado: (2015)

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression
por: Jacob SA, et al.
Publicado: (2015)

Neurosarcoidosis Presenting as Young-Onset Chronic Headache: A Case Report
por: Barun Kumar Ray, et al.
Publicado: (2021)

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
por: Armaly Z, et al.
Publicado: (2012)

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
por: Medic G, et al.
Publicado: (2013)

Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages
por: Hsiao-Wen Lin, et al.
Publicado: (2009)

Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s Republic of China
por: Zhang J, et al.
Publicado: (2013)

Paroxetine ameliorates changes in hippocampal energy metabolism in chronic mild stress-exposed rats
por: Khedr LH, et al.
Publicado: (2015)

Efficacy of physical activity counseling plus sleep restriction therapy on the patients with chronic insomnia
por: Wang J, et al.
Publicado: (2015)

Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
por: Takahiko Nagamine
Publicado: (2008)

Effectiveness of high-intensity interval training on the mental and physical health of people with chronic schizophrenia
por: Wu MH, et al.
Publicado: (2015)

Levetiracetam in the treatment of epilepsy
por: Bassel Abou-Khalil
Publicado: (2008)

Almotriptan in the treatment of migraine
por: Giorgio Sandrini, et al.
Publicado: (2007)

Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides
por: Malo-Urriés M, et al.
Publicado: (2018)

Chronic shoulder pain referred from thymic carcinoma: a case report and review of literature
por: Dee SW, et al.
Publicado: (2012)

Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan
por: Ryuji Kaji, et al.
Publicado: (2021)